Terms: = Liver cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1
144 results:
1. Introduction of robotic pancreatoduodenectomy following phase 2a IDEAL guidelines.
Mise Y; Miyashita M; Yoshioka R; Kawano F; Takeda Y; Ichida H; Saiura A
PLoS One; 2024; 19(5):e0302848. PubMed ID: 38709730
[TBL] [Abstract] [Full Text] [Related]
2. ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal liver Metastasis Resection.
Achterberg FB; Bijlstra OD; Slooter MD; Sibinga Mulder BG; Boonstra MC; Bouwense SA; Bosscha K; Coolsen MME; Derksen WJM; Gerhards MF; Gobardhan PD; Hagendoorn J; Lips D; Marsman HA; Zonderhuis BM; Wullaert L; Putter H; Burggraaf J; Mieog JSD; Vahrmeijer AL; Swijnenburg RJ;
JAMA Netw Open; 2024 Apr; 7(4):e246548. PubMed ID: 38639939
[TBL] [Abstract] [Full Text] [Related]
3. Applying image features of proximal paracancerous tissues in predicting prognosis of patients with hepatocellular carcinoma.
Lin S; Yong J; Zhang L; Chen X; Qiao L; Pan W; Yang Y; Zhao H
Comput Biol Med; 2024 May; 173():108365. PubMed ID: 38537563
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison.
Agirrezabal I; Bouattour M; Pinato DJ; D'Alessio A; Brennan VK; Carion PL; Shergill S; Amoury N; Vilgrain V
Eur J Cancer; 2024 Jan; 196():113427. PubMed ID: 37988840
[TBL] [Abstract] [Full Text] [Related]
6. An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease.
Kendall TJ; Jimenez-Ramos M; Turner F; Ramachandran P; Minnier J; McColgan MD; Alam M; Ellis H; Dunbar DR; Kohnen G; Konanahalli P; Oien KA; Bandiera L; Menolascina F; Juncker-Jensen A; Alexander D; Mayor C; Guha IN; Fallowfield JA
Nat Med; 2023 Nov; 29(11):2939-2953. PubMed ID: 37903863
[TBL] [Abstract] [Full Text] [Related]
7. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S; Chen M; Cheng AL; Kaseb AO; Kudo M; Lee HC; Yopp AC; Zhou J; Wang L; Wen X; Heo J; Tak WY; Nakamura S; Numata K; Uguen T; Hsiehchen D; Cha E; Hack SP; Lian Q; Ma N; Spahn JH; Wang Y; Wu C; Chow PKH;
Lancet; 2023 Nov; 402(10415):1835-1847. PubMed ID: 37871608
[TBL] [Abstract] [Full Text] [Related]
8. A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinoma.
Lei K; Deng Z; Wang J; Wang H; Hu R; Li Y; Wang X; Xu J; You K; Liu Z
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14631-14640. PubMed ID: 37584710
[TBL] [Abstract] [Full Text] [Related]
9. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal cancer.
Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
[TBL] [Abstract] [Full Text] [Related]
10. Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022.
Boggi U; Donisi G; Napoli N; Partelli S; Esposito A; Ferrari G; Butturini G; Morelli L; Abu Hilal M; Viola M; Di Benedetto F; Troisi R; Vivarelli M; Jovine E; Ferrero A; Bracale U; Alfieri S; Casadei R; Ercolani G; Moraldi L; Molino C; Dalla Valle R; Ettorre G; Memeo R; Zanus G; Belli A; Gruttadauria S; Brolese A; Coratti A; Garulli G; Romagnoli R; Massani M; Borghi F; Belli G; Coppola R; Falconi M; Salvia R; Zerbi A;
Updates Surg; 2023 Sep; 75(6):1439-1456. PubMed ID: 37470915
[TBL] [Abstract] [Full Text] [Related]
11. Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Endo Y; Yang J; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5406-5415. PubMed ID: 37210452
[TBL] [Abstract] [Full Text] [Related]
12. Risk Factors of Positive Resection Margin in Hepatectomy for Resectable Ruptured Hepatocellular Carcinoma: Risk Prediction and Prognosis.
Xia F; Zhang Q; Zheng J; Huang Z; Ndhlovu E; Gao H
J Gastrointest Surg; 2023 Jul; 27(7):1400-1411. PubMed ID: 37095336
[TBL] [Abstract] [Full Text] [Related]
13. Ovarian Granulosa Cell Tumor Initially Presenting as a Giant liver Mass Radiologically Mimicking Primary Cystic Cholangiocarcinoma.
Qian X; Cong Z; Lai J
In Vivo; 2023; 37(2):734-737. PubMed ID: 36881092
[TBL] [Abstract] [Full Text] [Related]
14. Clinical application of preoperative shear wave dispersion for prediction of post liver failure in patients with hepatocellular carcinoma after hepatectomy.
Wang K; Zhu Y; Bao J; Zhu Z; Dong Y; Han H; Wang W
Clin Hemorheol Microcirc; 2023; 85(3):223-234. PubMed ID: 36872770
[TBL] [Abstract] [Full Text] [Related]
15. Exploring the spectrum of incidental gastric polyps in autoimmune gastritis.
Massironi S; Elvevi A; Gallo C; Laffusa A; Tortorella A; Invernizzi P
Dig Liver Dis; 2023 Sep; 55(9):1201-1207. PubMed ID: 36858908
[TBL] [Abstract] [Full Text] [Related]
16. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract] [Full Text] [Related]
17. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract] [Full Text] [Related]
18.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract] [Full Text] [Related]
19. Radiomics signature based on CECT for non-invasive prediction of response to anti-PD-1 therapy in patients with hepatocellular carcinoma.
Cui H; Zeng L; Li R; Li Q; Hong C; Zhu H; Chen L; Liu L; Zou X; Xiao L
Clin Radiol; 2023 Feb; 78(2):e37-e44. PubMed ID: 36257868
[TBL] [Abstract] [Full Text] [Related]
20. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
[Next]
